Global Female Contraceptive Market Size, Share, Trends and Forecast 2021-2027

Description

The global Female Contraceptive market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
Global Female Contraceptive Scope and Segment
Female Contraceptive market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Female Contraceptive market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2016-2027.
The following manufacturers are covered in this report:
Merck
Pfizer
Allergan
Bayer
Okamoto Industries
Reckitt Benckiser
Lupin Pharmaceuticals
Foundation Consumer Healthcare
Teva Pharmaceuticals
Ansell
Ferring Pharmaceuticals
Fuji Latex
Janssen Pharmaceuticals
Female Contraceptive Breakdown Data by Type
Female Contraceptive Devices
Female Contraceptive Drugs
Female Contraceptive Breakdown Data by Application
Online Stores
Retail Outlets
Regional and Country-level Analysis
The Female Contraceptive market is analysed and market size information is provided by regions (countries).
The key regions covered in the Female Contraceptive market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2016-2027. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2016-2027.
Competitive Landscape and Female Contraceptive Market Share Analysis

TABLE OF CONTENT

1 Study Coverage
1.1 Female Contraceptive Product Introduction
1.2 Market by Type
1.2.1 Global Female Contraceptive Market Size Growth Rate by Type
1.4.2 Female Contraceptive Devices
1.4.3 Female Contraceptive Drugs
1.3 Market by Application
1.3.1 Global Female Contraceptive Market Size Growth Rate by Application
1.3.2 Online Stores
1.3.3 Retail Outlets
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Female Contraceptive Sales Estimates and Forecasts 2016-2027
2.2 Global Female Contraceptive Revenue Estimates and Forecasts 2016-2027
2.3 Global Female Contraceptive Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top Female Contraceptive Regions by Sales
2.4.1 Global Top Female Contraceptive Regions by Sales (2016-2021)
2.4.2 Global Top Female Contraceptive Regions by Sales (2022-2027)
2.5 Global Top Female Contraceptive Regions by Revenue
2.5.1 Global Top Female Contraceptive Regions by Revenue (2016-2021)
2.5.2 Global Top Female Contraceptive Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Female Contraceptive Sales by Manufacturers
3.1.1 Global Top Female Contraceptive Manufacturers by Sales (2016-2021)
3.1.2 Global Top Female Contraceptive Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by Female Contraceptive Sales in 2020
3.2 Global Female Contraceptive Revenue by Manufacturers
3.2.1 Global Top Female Contraceptive Manufacturers by Revenue (2016-2021)
3.2.2 Global Top Female Contraceptive Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by Female Contraceptive Revenue in 2020
3.3 Global Female Contraceptive Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Female Contraceptive Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Female Contraceptive Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Female Contraceptive Sales by Type
4.1.1 Global Female Contraceptive Historical Sales by Type (2016-2021)
4.1.2 Global Female Contraceptive Forecasted Sales by Type (2022-2027)
4.1.3 Global Female Contraceptive Sales Market Share by Type (2016-2027)
4.2 Global Female Contraceptive Revenue by Type
4.2.1 Global Female Contraceptive Historical Revenue by Type (2016-2021)
4.2.2 Global Female Contraceptive Forecasted Revenue by Type (2022-2027)
4.2.3 Global Female Contraceptive Revenue Market Share by Type (2016-2027)
4.3 Global Female Contraceptive Price by Type
4.3.1 Global Female Contraceptive Price by Type (2016-2021)
4.3.2 Global Female Contraceptive Price Forecast by Type (2022-2027)
5 Market Size by Application
5.1 Global Female Contraceptive Sales by Application
5.1.1 Global Female Contraceptive Historical Sales by Application (2016-2021)
5.1.2 Global Female Contraceptive Forecasted Sales by Application (2022-2027)
5.1.3 Global Female Contraceptive Sales Market Share by Application (2016-2027)
5.2 Global Female Contraceptive Revenue by Application
5.2.1 Global Female Contraceptive Historical Revenue by Application (2016-2021)
5.2.2 Global Female Contraceptive Forecasted Revenue by Application (2022-2027)
5.2.3 Global Female Contraceptive Revenue Market Share by Application (2016-2027)
5.3 Global Female Contraceptive Price by Application
5.3.1 Global Female Contraceptive Price by Application (2016-2021)
5.3.2 Global Female Contraceptive Price Forecast by Application (2022-2027)

6 North America
6.1 North America Female Contraceptive Market Size by Type
6.1.1 North America Female Contraceptive Sales by Type (2016-2027)
6.1.2 North America Female Contraceptive Revenue by Type (2016-2027)
6.2 North America Female Contraceptive Market Size by Application
6.2.1 North America Female Contraceptive Sales by Application (2016-2027)
6.2.2 North America Female Contraceptive Revenue by Application (2016-2027)
6.3 North America Female Contraceptive Market Size by Country
6.3.1 North America Female Contraceptive Sales by Country (2016-2027)
6.3.2 North America Female Contraceptive Revenue by Country (2016-2027)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Female Contraceptive Market Size by Type
7.1.1 Europe Female Contraceptive Sales by Type (2017-2027)
7.1.2 Europe Female Contraceptive Revenue by Type (2017-2027)
7.2 Europe Female Contraceptive Market Size by Application
7.2.1 Europe Female Contraceptive Sales by Application (2017-2027)
7.2.2 Europe Female Contraceptive Revenue by Application (2017-2027)
7.3 Europe Female Contraceptive Market Size by Country
7.3.1 Europe Female Contraceptive Sales by Country (2017-2027)
7.3.2 Europe Female Contraceptive Revenue by Country (2017-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Female Contraceptive Market Size by Type
8.1.1 Asia Pacific Female Contraceptive Sales by Type (2018-2027)
8.1.2 Asia Pacific Female Contraceptive Revenue by Type (2018-2027)
8.2 Asia Pacific Female Contraceptive Market Size by Application
8.2.1 Asia Pacific Female Contraceptive Sales by Application (2018-2027)
8.2.2 Asia Pacific Female Contraceptive Revenue by Application (2018-2027)
8.3 Asia Pacific Female Contraceptive Market Size by Region
8.3.1 Asia Pacific Female Contraceptive Sales by Region (2018-2027)
8.3.2 Asia Pacific Female Contraceptive Revenue by Region (2018-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Female Contraceptive Market Size by Type
9.1.1 Latin America Female Contraceptive Sales by Type (2019-2027)
9.1.2 Latin America Female Contraceptive Revenue by Type (2019-2027)
9.2 Latin America Female Contraceptive Market Size by Application
9.2.1 Latin America Female Contraceptive Sales by Application (2019-2027)
9.2.2 Latin America Female Contraceptive Revenue by Application (2019-2027)
9.3 Latin America Female Contraceptive Market Size by Country
9.3.1 Latin America Female Contraceptive Sales by Country (2019-2027)
9.3.2 Latin America Female Contraceptive Revenue by Country (2019-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
6 Middle East and Africa
6.1 Middle East and Africa Female Contraceptive Market Size by Type
6.1.1 Middle East and Africa Female Contraceptive Sales by Type (2016-2027)
6.1.2 Middle East and Africa Female Contraceptive Revenue by Type (2016-2027)
6.2 Middle East and Africa Female Contraceptive Market Size by Application
6.2.1 Middle East and Africa Female Contraceptive Sales by Application (2016-2027)
6.2.2 Middle East and Africa Female Contraceptive Revenue by Application (2016-2027)
6.3 Middle East and Africa Female Contraceptive Market Size by Country
6.3.1 Middle East and Africa Female Contraceptive Sales by Country (2016-2027)
6.3.2 Middle East and Africa Female Contraceptive Revenue by Country (2016-2027)
6.3.3 Turkey
6.3.4 Saudi Arabia
6.3.5 U.A.E

11 Company Profiles
11.1 Merck
11.1.1 Merck Corporation Information
11.1.2 Merck Overview
11.1.3 Merck Female Contraceptive Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Merck Female Contraceptive Product Description
11.1.5 Merck Related Developments
11.2 Pfizer
11.2.1 Pfizer Corporation Information
11.2.2 Pfizer Overview
11.2.3 Pfizer Female Contraceptive Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 Pfizer Female Contraceptive Product Description
11.2.5 Pfizer Related Developments
11.3 Allergan
11.3.1 Allergan Corporation Information
11.3.2 Allergan Overview
11.3.3 Allergan Female Contraceptive Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 Allergan Female Contraceptive Product Description
11.3.5 Allergan Related Developments
11.4 Bayer
11.4.1 Bayer Corporation Information
11.4.2 Bayer Overview
11.4.3 Bayer Female Contraceptive Sales, Price, Revenue and Gross Margin (2016-2021)
11.4.4 Bayer Female Contraceptive Product Description
11.4.5 Bayer Related Developments
11.5 Okamoto Industries
11.5.1 Okamoto Industries Corporation Information
11.5.2 Okamoto Industries Overview
11.5.3 Okamoto Industries Female Contraceptive Sales, Price, Revenue and Gross Margin (2016-2021)
11.5.4 Okamoto Industries Female Contraceptive Product Description
11.5.5 Okamoto Industries Related Developments
11.6 Reckitt Benckiser
11.6.1 Reckitt Benckiser Corporation Information
11.6.2 Reckitt Benckiser Overview
11.6.3 Reckitt Benckiser Female Contraceptive Sales, Price, Revenue and Gross Margin (2016-2021)
11.6.4 Reckitt Benckiser Female Contraceptive Product Description
11.6.5 Reckitt Benckiser Related Developments
11.7 Lupin Pharmaceuticals
11.7.1 Lupin Pharmaceuticals Corporation Information
11.7.2 Lupin Pharmaceuticals Overview
11.7.3 Lupin Pharmaceuticals Female Contraceptive Sales, Price, Revenue and Gross Margin (2016-2021)
11.7.4 Lupin Pharmaceuticals Female Contraceptive Product Description
11.7.5 Lupin Pharmaceuticals Related Developments
11.8 Foundation Consumer Healthcare
11.8.1 Foundation Consumer Healthcare Corporation Information
11.8.2 Foundation Consumer Healthcare Overview
11.8.3 Foundation Consumer Healthcare Female Contraceptive Sales, Price, Revenue and Gross Margin (2016-2021)
11.8.4 Foundation Consumer Healthcare Female Contraceptive Product Description
11.8.5 Foundation Consumer Healthcare Related Developments
11.9 Teva Pharmaceuticals
11.9.1 Teva Pharmaceuticals Corporation Information
11.9.2 Teva Pharmaceuticals Overview
11.9.3 Teva Pharmaceuticals Female Contraceptive Sales, Price, Revenue and Gross Margin (2016-2021)
11.9.4 Teva Pharmaceuticals Female Contraceptive Product Description
11.9.5 Teva Pharmaceuticals Related Developments
11.10 Ansell
11.10.1 Ansell Corporation Information
11.10.2 Ansell Overview
11.10.3 Ansell Female Contraceptive Sales, Price, Revenue and Gross Margin (2016-2021)
11.10.4 Ansell Female Contraceptive Product Description
11.10.5 Ansell Related Developments
11.1 Merck
11.1.1 Merck Corporation Information
11.1.2 Merck Overview
11.1.3 Merck Female Contraceptive Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Merck Female Contraceptive Product Description
11.1.5 Merck Related Developments
11.12 Fuji Latex
11.12.1 Fuji Latex Corporation Information
11.12.2 Fuji Latex Overview
11.12.3 Fuji Latex Female Contraceptive Sales, Price, Revenue and Gross Margin (2016-2021)
11.12.4 Fuji Latex Product Description
11.12.5 Fuji Latex Related Developments
11.13 Janssen Pharmaceuticals
11.13.1 Janssen Pharmaceuticals Corporation Information
11.13.2 Janssen Pharmaceuticals Overview
11.13.3 Janssen Pharmaceuticals Female Contraceptive Sales, Price, Revenue and Gross Margin (2016-2021)
11.13.4 Janssen Pharmaceuticals Product Description
11.13.5 Janssen Pharmaceuticals Related Developments

12 Value Chain and Sales Channels Analysis
12.1 Female Contraceptive Value Chain Analysis
12.2 Female Contraceptive Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Female Contraceptive Production Mode & Process
12.4 Female Contraceptive Sales and Marketing
12.4.1 Female Contraceptive Sales Channels
12.4.2 Female Contraceptive Distributors
12.5 Female Contraceptive Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Female Contraceptive Industry Trends
13.2 Female Contraceptive Market Drivers
13.3 Female Contraceptive Market Challenges
13.4 Female Contraceptive Market Restraints

14 Key Findings in The Global Female Contraceptive Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

Choose License Type

Checkout Inquiry Sample